Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The release notes now reflect the site version as v3.5.4, replacing the prior v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-15T06:51:27.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s footer version/revision label has been updated from 3.5.2 to 3.5.3, reflecting a maintenance/release update with no apparent change to the study’s recorded information.
    Difference
    0.1%
    Check dated 2026-04-24T05:42:38.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.5.2) and removed an older revision (v3.5.0) in the study record history; this is a metadata version update rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:09.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed on the Record History page, indicating a software update to the history tracking system.
    Difference
    0.1%
    Check dated 2026-03-19T05:12:47.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the history and removed Revision: v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:01.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    The history now includes an added Revision: v3.4.2 and the previous funding-status notice was removed, with no changes to the actual study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T10:59:24.000Z thumbnail image

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.